Evidence presented by different groups indicate that this hematologic disorder arises at the level of a HSC that is transformed by means of a chromosomal translocation, resulting in the generation of a chimeric gene (bcr‐abl), which encodes for an abnormally active tyrosine kinase. This evidence concerns the gene ABL1 and hematologic disorder.